Clinical trail to compare the effect two types of Nasya in Hyperpigmentation (Vyang) w.s.r.to Melasma
Phase 2
- Conditions
- Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
- Registration Number
- CTRI/2020/08/027067
- Lead Sponsor
- Dr Shivaleela kalyani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Diagnosed case of Vyanga and Melasma.
2) Patients with the age group between 18- 65years of either sex.
Exclusion Criteria
1) Vyanga along with Kushta roga to be excluded.
2) Hyperpigmentation caused by tumor like malignant melanoma
3) Women using oral contraceptives
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are targeted by Ayurvedic Nasya formulations in melasma treatment?
How does Nasya therapy compare to hydroquinone in clinical efficacy for melasma pigment reduction?
Which predictive biomarkers correlate with response to CTRI/2020/08/027067 Nasya interventions in melasma?
What are the safety profiles and adverse event management strategies for Ayurvedic nasal therapies in melasma?
What synergistic effects exist between Nasya and topical retinoids in addressing UV-induced melasma subtypes?